Related Experiment Videos
Improgan antinociception does not require neuronal histamine or histamine receptors
Jalal Izadi Mobarakeh1, Julia W Nalwalk, Takeshi Watanabe
1Department of Pharmacology, Tohoku University School of Medicine, Sendai, Japan.
Brain Research
|May 14, 2003
Summary
Improgan effectively reduces pain perception in mice, but this effect does not involve histamine receptors or the histamine biosynthetic enzyme. This suggests a novel mechanism for improgan
Area of Science:
- Neuroscience
- Pharmacology
- Pain Research
Background:
- Improgan, structurally similar to histamine and histamine blockers, is known to induce pain relief.
- The precise mechanism behind improgan's antinociceptive effects remains undetermined.
- Neuronal histamine is implicated in pain modulation, prompting investigation into its role with improgan.
Purpose of the Study:
- To elucidate the mechanism of action for improgan-induced antinociception.
- To determine if histamine receptors (H1, H2, H3) or histamine synthesis are involved in improgan's pain-relieving effects.
Main Methods:
- Administered improgan intracerebroventricularly to wild-type and genetically modified mice lacking histamine receptors or histidine decarboxylase.
- Assessed antinociceptive responses using thermal nociceptive tests.
- Evaluated improgan's in vitro inhibitory activity against recombinant rat H3 receptor isoforms (H3A, H3B, H3C).
Main Results:
- Improgan produced dose-related antinociception in wild-type mice.
- No significant differences in nociceptive responses were observed in mutant mice lacking histamine receptors or histidine decarboxylase compared to controls.
- Improgan exhibited weak in vitro inhibitory activity against H3 receptor isoforms.
Conclusions:
- Neuronal histamine and its receptors do not play a role in improgan-induced antinociception.
- The findings suggest that improgan's pain-relieving mechanism operates independently of the histamine system.